Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Hink

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Annals of the New York Academy of Sciences|July 23, 1999
Role for NADPH/NADH oxidase in the modulation of vascular toneT Münzel, U Hink, T Heitzer, et al.
Biochemical and Biophysical Research Communications|July 24, 1998
Quantification of superoxide radical formation in intact vascular tissue using a Cypridina luciferin analog as an alternative to lucigeninM P Skatchkov, D Sperling, U Hink, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1994
Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockadeW Auch-Schwelk, E Duske, U Hink, et al.
British Journal of Pharmacology|August 24, 1999
Role of superoxide dismutase in in vivo and in vitro nitrate toleranceT Münzel, U Hink, H Yigit, et al.
Circulation|June 22, 1999
Evidence for a causal role of the renin-angiotensin system in nitrate toleranceS Kurz, U Hink, G Nickenig, et al.
Biochemical and Biophysical Research Communications|January 27, 1999
Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide productionM P Skatchkov, D Sperling, U Hink, et al.
Kidney International|January 20, 1999
Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase CT Heitzer, U Wenzel, U Hink, et al.
Circulation Research|January 11, 2000
Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailabilityT Münzel, H Li, H Mollnau, et al.
Circulation|May 23, 2001
Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aortaA Mülsch, M Oelze, S Klöss, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1996
The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylationD H Walter, U Hink, T Asahara, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Annals of the New York Academy of Sciences|July 23, 1999
Role for NADPH/NADH oxidase in the modulation of vascular toneT Münzel, U Hink, T Heitzer, et al.
Biochemical and Biophysical Research Communications|July 24, 1998
Quantification of superoxide radical formation in intact vascular tissue using a Cypridina luciferin analog as an alternative to lucigeninM P Skatchkov, D Sperling, U Hink, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1994
Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockadeW Auch-Schwelk, E Duske, U Hink, et al.
British Journal of Pharmacology|August 24, 1999
Role of superoxide dismutase in in vivo and in vitro nitrate toleranceT Münzel, U Hink, H Yigit, et al.
Circulation|June 22, 1999
Evidence for a causal role of the renin-angiotensin system in nitrate toleranceS Kurz, U Hink, G Nickenig, et al.
Biochemical and Biophysical Research Communications|January 27, 1999
Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide productionM P Skatchkov, D Sperling, U Hink, et al.
Kidney International|January 20, 1999
Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase CT Heitzer, U Wenzel, U Hink, et al.
Circulation Research|January 11, 2000
Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailabilityT Münzel, H Li, H Mollnau, et al.
Circulation|May 23, 2001
Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aortaA Mülsch, M Oelze, S Klöss, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|February 1, 1996
The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylationD H Walter, U Hink, T Asahara, et al.
Pageof 2